February, 2023 - BioHarvest Sciences

BIOHARVEST SCIENCES ANNOUNCES A PRIVATE PLACEMENT OF UP TO CAD $8M OF CONVERTIBLE NOTES TO GROW CORE BUSINESS

2023 / Justin Meiklem

VANCOUVER, CANADA, AND REHOVOT, ISRAEL, February 21, 2023 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTC:CNVCF) announced today…

BIOHARVEST SCIENCES ANNOUNCES A PRIVATE PLACEMENT OF UP TO CAD $8M OF CONVERTIBLE NOTES TO GROW CORE BUSINESS Read More »

February 2023

BIOHARVEST SCIENCES ANNOUNCES A PRIVATE PLACEMENT OF UP TO CAD $8M OF CONVERTIBLE NOTES TO GROW CORE BUSINESS

BIOHARVEST SCIENCES COLLABORATING WITH YO MURPHY AND NFL PROSPECTS TO BUILD AWARENESS OF BLOOD FLOW IMPORTANCE

BIOHARVEST SCIENCES ANNOUNCES CLINICAL STUDY IN PATIENTS WITH MULTIPLE SCLEROSIS-RELATED OPTIC NEURITIS

BIOHARVEST SCIENCES REPORTS 2022 SALES ORDERS OF USD 6.1M REPRESENTING 2.6X INCREASE OVER 2021

Join Our Newsletter